Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

The China-based trial enrolled 398 patients who were randomised to the ivonescimab and Keytruda arms at a one-to-one ratio.

VEOCELtm, the flagship specialty nonwovens brand of Lenzing Group, highlighted its commitment to innovation and providing solutions to help address the global plastic crisis at the "SEA of Solutions ...

The global diabetic nephropathy market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 6% during the ...

Farm Animal Drug Market reaching a valuation of USD 33,211.3 million by 2034 at a Compound Annual Growth Rate (CAGR) of 5.5%.

Oral Solid Dosage Pharmaceutical Formulation Market is projected to achieve US$ 8,95,636.0 million by 2034 at a CAGR of 3.7%.